Angiodynamics (ANGO) EBIT Margin Growth (3y) (2013 - 2026)
Powered by 
Analysis
Angiodynamics (ANGO) EBIT Margin Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.94 Bn | 175.34 Bn | 7.27 Bn | -201.00 |
| 2 | Intuitive Surgical | 127.83 Bn | 122.62 Bn | 1.96 Bn | 722.00 |
| 3 | Medtronic | 116.96 Bn | 108.14 Bn | 6.34 Bn | 162.00 |
| 4 | Stryker | 104.44 Bn | 100.97 Bn | 4.50 Bn | 586.00 |
| 5 | Boston Scientific | 63.87 Bn | 63.33 Bn | 3.85 Bn | 736.00 |
| 6 | Edwards Lifesciences | 49.91 Bn | 45.65 Bn | 1.35 Bn | 887.00 |
| 7 | Alcon | 33.06 Bn | 31.60 Bn | 1.68 Bn | -1,075.00 |
| 8 | Dexcom | 32.22 Bn | 30.27 Bn | 830.00 Mn | 963.00 |
| 9 | Steris | 20.68 Bn | 20.20 Bn | 684.20 Mn | 244.00 |
| 10 | Angiodynamics | 626.63 Mn | 572.76 Mn | 46.77 Mn | 1,111.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 1,111.00 |
| Feb 28, 2026 | -545.00 |
| Nov 30, 2025 | 179.00 |
| Aug 31, 2025 | 224.00 |
| May 31, 2025 | 13.00 |
| Feb 28, 2025 | -669.00 |
| Nov 30, 2024 | -414.00 |
| Aug 31, 2024 | -888.00 |
| May 31, 2024 | 774.00 |
| Feb 29, 2024 | -26,063.00 |
| Nov 30, 2023 | -995.00 |
| Aug 31, 2023 | 5,182.00 |
| May 31, 2023 | 24,560.00 |
| Feb 28, 2023 | -212.00 |
| Nov 30, 2022 | -461.00 |
| Aug 31, 2022 | -1,506.00 |
| May 31, 2022 | -1,147.00 |
| Feb 28, 2022 | -155.00 |
| Nov 30, 2021 | -748.00 |
| Aug 31, 2021 | -94.00 |